COMMUNIQUÉS West-GlobeNewswire

Septerna to Participate in Upcoming Investor Conferences
01/09/2026
SOUTH SAN FRANCISCO, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today [...]
VivoSim Labs to Add Rat Liver Model to NAMkind Platform
01/09/2026
New cross-species capability is designed to help pharma distinguish rat-specific liver toxicity from risks that may translate to humans SAN DIEGO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) ( [...]
Biomerica Reports Fiscal 2026 Year-End Financial Results
01/09/2026
Fiscal 2026 fourth quarter net sales increased approximately 17% compared to the fourth quarter of fiscal 2025 Full-year net loss improved by approximately 24% to approximately $3.8 million InFoods IBS update: 100% of [...]
Autonomix Medical Announces Acceptance of Two Abstracts for Poster Presentation at CIRSE 2026
01/09/2026
Abstracts highlight potential of Autonomix’s transvascular technology across pain management and nervous system mapping THE WOODLANDS, TX, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“ [...]
Spectral AI to Present at H.C. Wainwright 28th Annual Global Investment Conference
01/09/2026
Company to Highlight Growth Strategy and Readiness for 2026 Commercial Launch of FDA-Cleared DeepView® System for Burn Indication DALLAS, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI [...]
Conexeu Sciences Sets September and October 2026 Conference Schedule
01/09/2026
RENO, Nev., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Conexeu Sciences Inc. (Nasdaq: CNXU) (“Conexeu” or the “Company”), a preclinical-stage biotechnology company advancing an investigational tissue-restoration platform, is [...]
Tris Pharma to Showcase ADHD Leadership and Commitment to Individualized Care at Fall 2026 Medical Conferences
01/09/2026
Company will exhibit at five major conferences this fall, engaging psychiatrists, pediatricians, child and adolescent psychiatrists, and the broader ADHD community Sponsored product theater presentations at US Psych [...]
SAB BIO to Participate in Upcoming Investor Conferences
01/09/2026
MIAMI, Sept. 01, 2026 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS ), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and [...]
Polaryx Therapeutics Appoints Dr. Will Charlton as Chief Medical Officer
01/09/2026
Dr. Charlton brings over 15 years of rare disease and pediatric drug development experience including CMO and clinical development roles Appointment further strengthens clinical leadership and execution capabilities [...]
Intelligent Bio Solutions Announces Private Placement of up to $15 Million to a Single Existing Institutional Investor Priced At-the-Market Under Nasdaq Rules
01/09/2026
$5 Million Upfront at Closing and $5 Million Tranche Warrant Callable by the Company Following FDA 510(k) Clearance of Intelligent Fingerprinting Drug Screening System NEW YORK, Sept. 01, 2026 (GLOBE NEWSWIRE) -- [...]
Celcuity To Participate in Upcoming Investor Conferences
01/09/2026
MINNEAPOLIS, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a biotechnology company focused on developing and commercializing targeted therapies for the treatment of multiple solid tumor indications, [...]
DnaK Therapeutics & GATC Health Forge A Partnership To Evaluate, Accelerate & Prioritize Cancer Drug Candidates Using AI Platform
01/09/2026
The collaboration will utilize predictive artificial intelligence for identifying the most promising molecules from an expansive pipeline that will substantially accelerate proof of concept timelines and markedly reduce [...]
CytoDyn Closes $16.5 Million Financing to Fund Continued Development of Leronlimab
01/09/2026
VANCOUVER, Washington, Sept. 01, 2026 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized monoclonal antibody [...]
SCYNEXIS to Participate in Upcoming Investor Conferences
01/09/2026
JERSEY CITY, N.J., Sept. 01, 2026 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (Nasdaq: SCYX), a clinical-stage biotechnology company focused on developing innovative therapies for severe and difficult-to-treat diseases with [...]
CorMedix Therapeutics to Participate in the Wells Fargo Healthcare Conference
01/09/2026
PARSIPPANY, N.J., Sept. 01, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and [...]
Intelligent Bio Solutions Achieves Above 98% Accuracy in Method Comparison Study, Supporting Planned 2026 FDA 510(k) Submission
01/09/2026
Multi-site clinical study delivers strong performance data for Intelligent Fingerprinting Drug Screening System NEW YORK, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the " [...]
Easy Environmental Solutions Reports Fiscal 2026 Results and Continued Revenue Growth
01/09/2026
Annual filing reflects substantial year-over-year revenue growth, improved operating performance and positive operating cash flow MANKATO, Minn., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Easy Environmental Solutions, Inc. ( [...]
Aeroflow Health Partners with Fallon Health to Expand DME Access to Commercial and Medicare Members in Massachusetts
01/09/2026
Commercial and Medicare members under Fallon Health gain easy access to critical care supplies such as breast pumps and CPAPs. ASHEVILLE, N.C., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Aeroflow Health , a technology-enabled [...]
Patients Suffering from Primary Biliary Cholangitis (PBC) Push Back on Stigma
01/09/2026
National Voice of PBC Survey Unveils the Significant Physical, Emotional and Social Impact of PBC ROCHESTER, N.Y., Sept. 01, 2026 (GLOBE NEWSWIRE) -- This September, in recognition of PBC Awareness Month, The PBCers [...]

Pages